These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16586392)

  • 21. Assessment of the bio-preparedness and of the training of the French hospital laboratories in the event of biological threat.
    Merens A; Cavallo JD; Thibault F; Salicis F; Munoz JF; Courcol R; Binder P
    Euro Surveill; 2012 Nov; 17(45):. PubMed ID: 23153476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A national laboratory network for bioterrorism: evolution from a prototype network of laboratories performing routine surveillance.
    Gilchrist MJ
    Mil Med; 2000 Jul; 165(7 Suppl 2):28-31. PubMed ID: 10920634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel bioterrorism responders: are hospital labs ready?
    York M
    MLO Med Lab Obs; 2003 Aug; 35(8):12-7, 19; quiz 22-3. PubMed ID: 12942658
    [No Abstract]   [Full Text] [Related]  

  • 24. Laboratory safety practices associated with potential agents of biocrime or bioterrorism.
    Sewell DL
    J Clin Microbiol; 2003 Jul; 41(7):2801-9. PubMed ID: 12843004
    [No Abstract]   [Full Text] [Related]  

  • 25. [From alert to laboratory: a coherent network designed to deal with to naturally occurring infectious disease outbreaks and bioterrorism].
    Binder P; Brucker G; Josseran L
    Bull Acad Natl Med; 2007 Jun; 191(6):1005-18. PubMed ID: 18402161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthrax 2001--lessons learned by public health laboratories.
    Heatherley SS
    Clin Lab Sci; 2002; 15(3):183-6. PubMed ID: 12778966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is your laboratory prepared for a bioterrorism attack?
    Szabo J
    MLO Med Lab Obs; 2001 Dec; 33(12):10-6; quiz 20-1. PubMed ID: 11799622
    [No Abstract]   [Full Text] [Related]  

  • 28. Health plans mobilize national bioterrorism response.
    Rehm B; Bocchino C
    Healthplan; 2002; 43(3):38-42. PubMed ID: 12068730
    [No Abstract]   [Full Text] [Related]  

  • 29. A conceptual framework for evaluating information technologies and decision support systems for bioterrorism preparedness and response.
    Bravata DM; McDonald KM; Szeto H; Smith WM; Rydzak C; Owens DK
    Med Decis Making; 2004; 24(2):192-206. PubMed ID: 15090105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leadership principles for developing a statewide public health and clinical laboratory system.
    Marshall SA; Brokopp CD; Size T
    Public Health Rep; 2010; 125 Suppl 2(Suppl 2):110-7. PubMed ID: 20518452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of animals as a surveillance tool for monitoring environmental health hazards, human health hazards and bioterrorism.
    Neo JPS; Tan BH
    Vet Microbiol; 2017 May; 203():40-48. PubMed ID: 28619165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of policies in activating the Infectious Disease Specialist Network (IDSN) for bioterrorism events].
    Kim YS
    J Prev Med Public Health; 2008 Jul; 41(4):214-8. PubMed ID: 18664726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animals as early detectors of bioevents: veterinary tools and a framework for animal-human integrated zoonotic disease surveillance.
    Gubernot DM; Boyer BL; Moses MS
    Public Health Rep; 2008; 123(3):300-15. PubMed ID: 19006972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biothreat Agents and Emerging Infectious Disease in the Emergency Department.
    Adalja AA
    Emerg Med Clin North Am; 2018 Nov; 36(4):823-834. PubMed ID: 30297007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interview with Mark Klempner, MD, principal investigator, National Emerging Infectious Diseases Laboratories, and associate provost for research, Boston University School of Medicine.
    Klempner M
    Biosecur Bioterror; 2006; 4(2):107-12. PubMed ID: 16792478
    [No Abstract]   [Full Text] [Related]  

  • 36. The pitfalls of bioterrorism preparedness: the anthrax and smallpox experiences.
    Cohen HW; Gould RM; Sidel VW
    Am J Public Health; 2004 Oct; 94(10):1667-71. PubMed ID: 15451727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will the nation be ready for the next bioterrorism attack? Mending gaps in the public health infrastructure.
    Salinsky E
    NHPF Issue Brief; 2002 Jun; (776):1-19. PubMed ID: 12083160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe.
    Donoso Mantke O; Schmitz H; Zeller H; Heyman P; Papa A; Niedrig M;
    Euro Surveill; 2005 Jun; 10(6):102-6. PubMed ID: 16077216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of biosurety systems in a Department of Defense medical research laboratory.
    Carr K; Henchal EA; Wilhelmsen C; Carr B
    Biosecur Bioterror; 2004; 2(1):7-16. PubMed ID: 15068675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
    Sundqvist B; Bengtsson UA; Wisselink HJ; Peeters BP; van Rotterdam B; Kampert E; Bereczky S; Johan Olsson NG; Szekely Björndal A; Zini S; Allix S; Knutsson R
    Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.